U
OXFD

UBS’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

UBS’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$20K Sell
1,311
-567
-30% -$8.68K ﹤0.01% 8037
2014
Q2 		$32K Buy
1,878
+1,778
+1,778% +$32K ﹤0.01% 7475
2014
Q1 		$2K Buy
100
+16
+19% +$346 ﹤0.01% 10087
2013
Q4 		$2K Buy
+84
New +$1.49K ﹤0.01% 10085

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS's OXFD Position: Q3 2014 in Review

UBS reduced its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 30% in Q3 2014, selling an estimated $8.68K and leaving 1,311 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #8037.

UBS first reported a position in OXFD in Q4 2013 and has held it in 4 quarters since. The position peaked at $32K in Q2 2014. 49 funds tracked by Wall St. Rank hold OXFD as of Q3 2014.

  • UBS held 1,311 shares of Oxford Immunotec Global PLC Ordinary Shares worth $20K as of Q3 2014.
  • UBS sold 567 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2014, an estimated $8.68K.
  • Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of UBS's portfolio in Q3 2014, its #8037 holding.
  • UBS first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 4 quarters since.
  • UBS's Oxford Immunotec Global PLC Ordinary Shares position peaked at $32K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.